Conjunctivitis Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class; By Disease Type; By Route of Administration (Topical, Oral); By Formulation Type; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032

Conjunctivitis Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class; By Disease Type; By Route of Administration (Topical, Oral); By Formulation Type; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032

The global conjunctivitis treatment market size is expected to reach USD 5.83 billion by 2032, according to a new study by Polaris Market Research. The report “Conjunctivitis Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class; By Disease Type; By Route of Administration (Topical, Oral); By Formulation Type; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

An increasing incidence of conjunctivitis is the primary driver for the growth of the conjunctivitis treatment market. Moreover, the strong focus of the industry players towards the research & development for the introduction of more effective treatment and increasing healthcare spending is expected to contribute to the market growth throughout the forecast period. Furthermore, sharing of clothes, eye contact with contaminated objects, hand-to-eye contact, and mutual usage of personal & cosmetic products increases the risk of conjunctivitis, which ultimately propels the demand for its treatment.

The introduction of new technologies in the field of ophthalmology treatment, the increasing number of patient visits for regular eye checkups, and rapid growth in the number of people seeking medical treatment for conjunctivitis are anticipated to fuel the expansion of the conjunctivitis treatment market in the coming years. Moreover, a growing number of people with low vitamin D levels are more likely to be infected with severe conjunctivitis. For instance, according to a research study of tears from around 335 conjunctivitis patients at the Narayana Nethralaya’s GROW (Genes Repair & Regeneration in Ophthalmic Workstation) Lab, nearly 60% of the 220 patients also had low levels of Vitamin D. Thus, an increasing number of patients with low vitamin D levels are expected to fuel the overall market growth.

Moreover, the strong preference of consumers for topical medications coupled with an increasing number of product launches that are applied topically will drive the market expansion. Furthermore, many ongoing clinical trials for the introduction of new products are expected to provide significant growth opportunities for the market growth.

Conjunctivitis Treatment Market Report Highlights

The anti-allergic segment dominated the market, owing to the growing incidence rate of ocular allergies.

The allergic conjunctivitis segment held the largest market share, owing to an increasing number of patients suffering from the disease.

The topical segment accounted for the largest share of the market, owing to the ability of this type of treatment to deliver the drug at the appropriate sites of infection.

The tablets & capsules segment captured the largest market share, owing to the rising prescription volume of tablets for conjunctivitis.

North America accounted for the largest market share, owing to the high prevalence of conjunctivitis and strong focus of companies towards new product launches.

The market players include Abbvie Inc, Novartis, Bausch Health Companies Inc., Harrow, NicOx SA, Alembic Pharmaceuticals, AFT Pharmaceuticals, etc.

Polaris Market Research has segmented the conjunctivitis treatment market report based on drug class, disease type, route of administration, formulation type, distribution channel, and region:

Conjunctivitis Treatment, Drug Class Outlook (Revenue - USD Billion, 2019 - 2032)

Antibiotics

Antiviral

Anti-allergic

Artificial Tears

Others

Conjunctivitis Treatment, Disease Type Outlook (Revenue - USD Billion, 2019 - 2032)

Bacterial Conjunctivitis

Viral Conjunctivitis

Allergic Conjunctivitis

Conjunctivitis Treatment, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

Topical

Oral

Conjunctivitis Treatment, Formulation Type Outlook (Revenue - USD Billion, 2019 - 2032)

Tablets & Capsules

Drops

Others

Conjunctivitis Treatment, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies & Drug Stores

Conjunctivitis Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa